A patient with a rare illness would have died if it weren't for AI-powered drug repurposing: When side effects come to the ...

REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer, according to the Oregon State ...

Regeneron Pharmaceuticals Inc. closed 44.49% short of its 52-week high of $1,211.20, which the company reached on August 27th ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its ...

The global pressure transmitter market is expected to be USD 3.84 billion by 2030 from USD 3.21 billion from 2025, at a CAGR of 3.7% during the forecast period according to a new report by ...

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...

The Global Market for Micro Bioreactor System was estimated to be worth USD 134.7 Million in 2023 and is forecast to a readjusted size of USD 276.7 Million by 2030 with a CAGR of 10.7% during the ...

Together with the previous data that azenosertib synergized with TOPO1 inhibitor based ADCs, these results indicate that azenosertib could be used as a generalizable combination partner with ADCs for ...

CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western studyFast Track Designation granted by FDA for CRB-701 to ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE ... Under this segment, Innocan focuses on advanced, targeted online sales, through its BI Sky ...